US2015202156A1PendingUtilityA1
Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition
Est. expiryApr 23, 2024(expired)· nominal 20-yr term from priority
A61K 9/0075A61K 31/192A61K 31/58A61K 9/145A61K 9/14A61K 31/573A61K 9/143A61K 9/0078
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Pharmaceutical composition in a dry powder form comprising at least one hydrophobic active principle, at least one water-soluble excipient and at least one surfactant, wherein the particles in said dry powder state have a Volume Mean Diameter VMD d greater than the Volume Mean Diameter VMD w of particles in a suspension obtained from said pharmaceutical composition at standard conditions of dispersion in a water-medium. It is also disclosed a process to prepare such dry composition and an extemporaneous suspension for inhalation therapy obtainable from said dry composition.
Claims
exact text as granted — not AI-modified1 . Process for the preparation of a dry powder pharmaceutical composition comprising at least one hydrophobic active principle, at least one water-soluble excipient, and at least one surfactant, in which the Volume Mean Diameter VMD d of the particles in said solid dry composition is greater than the Volume Mean Diameter VMD w of the particles in a suspension obtained from said pharmaceutical composition at standard conditions of dispersion in a water-medium, said process comprising the following steps:
a) preparing a first phase (A) which is a solution of said hydrophobic active principle in an organic solvent; b) preparing a second phase (B) in which one or more water-soluble excipients are dissolved in an aqueous medium; c) dissolving the surfactants in either one of phase (A) or phase (B); d) mixing said phases (A) and (B) to obtain a phase (C) in which the liquid medium is homogeneous; e) drying said phase (C) in order to obtain a dry powder with particle size between 0.1 and 17.5 μm; f) collecting said dry powder;
wherein said surfactant and active principle have a weight-to-weight ratio in said particles comprised between 0.6 and 40.
2 . Process according to claim 1 , wherein said organic solvent is miscible with water.
3 . Process according to claim 2 , wherein said organic solvent is an alcohol.
4 . Process according to claim 3 , wherein said alcohol is ethyl alcohol.
5 . Process according to claim 1 , wherein said step d) of drying said phase (C) is a spray drying process.
6 . Process according to claim 1 , wherein said particle size, expressed as VMD d , is comprised between 0.1 and 175 μm.Join the waitlist — get patent alerts
Track US2015202156A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.